CURRICULUM VITAE

Fateh Entabi, M.D.

President at Entabi, MD Inc

Clinical Instructor, UC Davis

Mailing address:

PO Box 3064

Visalia, CA 93278-3064

Office address:

1070 North Cherry St.

Tulare, CA 93274

Tel : (559) 412-5533

Fax: (559) 412-5534

Mail:

Site:www.fatehentabi.com

Cell: (559) 410-5260

Personal

Born in: Damascus, Syria 1977

Citizenship: US Citizen

Board Certification

American Board of Surgery March, 7th, 2016 Certificate: 061195

Current positions

President at Entabi, MD Inc., (October 2013-present): Performing elective and emergent operations at private office and at Tulare Regional Medical Center

Please see on-line patient reviews of my practice: https://www.patientfusion.com/doctor/fateh-entabi-md-96734

Surgical Hospitalist at Tulare Regional Medical Center (October 2013-present): Taking emergency room calls and performing emergent surgeries

Surgical Hospitalist Mee Memorial hospital (October 2014-present): Taking emergency room calls and covering hospital clinic

Altura Centers for Health (June 2015- present): Providing outpatient care

Academic appointment

University of California Davis: Clinical Instructor Dec 3rd, 2015- present

Current hospital privileges

Tulare Regional Medical Center: Tulare, CA

Mee Memorial Hospital: King City, CA

Ladenhiem Dialysis Access Center: Fresno, CA

Patent ownership

Surgical Tools and System for Safely Accessing Body Cavities and Methods of Using the Same. Patent pending (Filed Mar 2015)

Previous position

Surgical Hospitalist with Mineral King Surgical Associates at Kaweah Delta Health District July2013 - October 2013, Visalia, CA 93292. (group was dissolved)

Professional Interests

I am especially interested in performing emergency general surgery, advanced laparoscopy, skin lesions (benign/malignant), breast, dialysis access, basic fluoroscopy guided procedures, and peri-anal surgery.

I use my experience with patients as a tool for innovation and constantly conduct searches in current literature to improve patient outcomes. I have very high standards for the care of my patients and would prefer an environment that strongly supports evidence-based medicine and apply the highest standards in patient care.

Licensure

The Medical Board of California since February 2013

Residency

July2007- June 2013 Categorical Resident in surgery/ Research Fellow

University of Pittsburgh Medical Center, Pittsburgh, PA

July 2006-Jun 2007: PGY 1 Categorical Resident in Surgery

Graduate Hospital, Philadelphia, PA

December 2005- June 2006: PGY1 Preliminary Resident in Surgery

Mayo Clinic, Rochester, MN

Education

August, 1994 - April 2003: Medical School, University of Damascus, Syria

December, 2002 –January 2003: Surgery Elective, Harvard Medical School

October, 2002- December 2002: Surgery Elective, Baylor College of Medicine

August, 1999- October 1999: Surgery Elective, American University of Beirut

Research Experience

July, 2009 – June2011: Research Fellow

University of Pittsburgh Medical Center, Pittsburgh, PA

August, 2003 - December 2005: Research Fellow

Massachusetts General Hospital- Harvard Medical

School, Vascular Surgery Department

Research Grants:

1. Resident Research Scholarship from the American College of Surgeons (one of six given within the US)

2. NIH Institutional Research Training grant T32

Awards:

American College of Surgeons Resident Research Scholarship 2009-2011

Professional Organizations:

American College of Surgeons Active Member since 2006

Mayo Clinic Alumni since June 2006

Association of Academic Surgeons Active Member since 2009

Allegheny County Medical Society Member since 2007

Pennsylvania Medical Society Member since 2006

Cooperative of American Physicians Member since 2013

American Medical Association Member since April 2014

Peer Reviewed Publications/book Chapters:

1. Eid GM, Wikiel KJ, Entabi F, Saleem M Ventral Hernias in Morbidly Obese Patients: a suggested algorithm for operative repair. Obes Surg. 2013 May; 23(5): 703-9.

2. Eid GM, Entabi F, Watson AR, Zuckerbraun BS, Wilson MA. Robotic-assisted laparoscopic side-to-side lateral pancreaticojejunostomy.J Gastrointest Surg. 2011 Jul;15(7):1243

3. Entabi F, Ochoa J (book published by Jp Medial)- Jp Medical Pub Surgical Oncology: Fundamentals, Evidence Based Approaches and New Technologies. Nutrition chapter David L. Bartlett ISBN 9350250519 (2011)

4. Hsu WM, Carraro A, Kulig KM, Miller ML, Kaazempur-Mofrad M, Weinberg E, Entabi F, Albadawi H, Watkins MT, Borenstein JT, Vacanti JP, Neville C.Liver-Assist Device With a Microfluidics-Based Vascular Bed in an Animal Model. Ann Surg. 2010 Jul 19.

5. Stone DH, Conrad MF, Albadawi H, Entabi F, Stoner MC, Cambria RP, Watkins MT. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury. Vasc Endovascular Surg. 2009 Oct-Nov;43(5):444-51. Epub 2009 Jul 29.

6. Stone DH, Albadawi H, Conrad MF, Entabi F, Stoner MC, Casey PJ, Cambria RP, Watkins MT. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion. Am J Surg. 2009 Aug;198(2):250-5. Epub 2009 Mar 6.

7. Hua HT, Albadawi H, Entabi F, Conrad MF, Stoner MC, Houser S, Watkins MT. Effects of acute global venous obstruction and unfractionated heparin on muscle cytokine synthesis. Ann Vasc Surg. 2009 Jan-Feb;23(1):108-15. Epub 2008 Jul

8. Fateh Entabi , Hassan Albadawi, David H. Stone, Rameses Sroufe, Mark F. Conrad, Michael T. Watkins. Hind Limb Ischemia-Reperfusion in the Leptin Receptor Deficient (db/db) Mouse, Journal of Surgical Research
1 May 2007 (Vol. 139, Issue 1, Pages 97-105)

9. Entabi F, Albadawi H, Stone DH, Sroufe R, Conrad MF, Watkins MT. Journal of Surgical Research. Hind Limb Ischemia-Reperfusion in the Leptin Receptor Deficient (db/db) Mouse. Volume 139, Issue 1, Pages 97-105, Feb 2007

10. Crawford R, Faraz F. Hashmi, Jones J, Albadawi H, McCormack M, Eberlin K, Entabi F, Atkins M, Conrad M, Austen G, Jr, and Watkins M. A novel model of acute murine hindlimb ischemia Am J Physiol Heart Circ Physiol 292: H830-H837,2007.; doi:10.1152/ajpheart.00581.2006 Sep, 2006

11. Conrad MF, Albadawi H, Stone DH, Crawford RS, Entabi F, Watkins MT. Journal of Surgical Research Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury. 135(2):233-7, Oct 2006

12. F. Entabi, H. Albadawi, R.S. Crawford, J. Jones, M.D. Atkins, M.F. Conrad, M.T. Watkins. PARP inhibition confers protection against limb ischemia-reperfusion injury in diabetic rodents. Journal of Surgical Research. February 2006 (Vol. 130, Issue 2, Page 272)

13. F. Entabi, H. Albadawi, R.S. Crawford, J. Jones, M.D. Atkins, M.T. Watkins Recovery impairment in diabetic rodents after limb ischemia-reperfusion. Journal of Surgical Research. February 2006 (Vol. 130, Issue 2, Pages 271-272)

14. J.E. Jones, H. Al-Badawi, M.D. Atkins, F. Entabi, D.H. Stone, M.T. Watkins The absence of Toll-like receptor-4 does not improve survival or protect against spinal cord injury after thoracic aortic ischemia reperfusion in mice. Journal of Surgical Research February 2006 (Vol. 130, Issue 2, Page 272)

15. David Stone, Mark Conrad, Hassan AlBadawi, Fateh Entabi, Richard Cambria, Michael Watkins. COX-2 inhibition enhances spinal cord mitochondrial activity in a murine model of thoracic aortic ischemia reperfusion. Journal of the American College of Surgeons. September 2005 (Vol. 201, Issue 3, Supplement, Page S106)

16. Hassan Albadawi, Fateh Entabi, Mark Conrad, David Stone, Michael Watkins Novel role of toll-like receptor 4 in limb ischemia-reperfusion. Journal of the American College of Surgeons. Sep. 2005 (Vol. 201, Issue 3, Supplement, Page S101)

17. Entabi F, Watkins MT., (Book published by CRC Press), Nutrition and Diabetes: Pathophysiology and Management, Opara EC / Chapter 20, ISBN: 084932307X, Nov, 2005

18. Stone DH, AlBadawi H, Conrad MF, Entabi F, Stoner MC, Cambria RP, Watkins MT, Surgery, Volume: 138, Issue: 2, Pages: 368-74, PJ34, A Poly-ADP Ribose Polymerase Inhibitor, Modulates Renal Injury Following Thoracic Aortic Ischemia Reperfusion. Aug, 2005

19. Conrad MF, Stone DH, Albadawi H, Hua HT, Entabi F, Stoner MC and Watkins MT, Surgery Volume: 138, Issue: 2, Pages: 375-81, Local inflammatory and Thrombotic Responses Differ in a Murine Model of Partial and Complete Hindlimb Ischemia and Reperfusion. Aug, 2005

20. Hua HT, Albadawi H, Entabi F, Stoner MC, Meriam BT, Sroufe R, Watkins MT, Journal of Vascular Surgery, CXC Chemokine Expression and Synthesis in Skeletal Muscle during Ischemia Reperfusion, Volume: 42, Issue 2, Pages: 337- 343 Aug, 2005

21. Hua HT, Albadawi H, Entabi F, Conrad M, Stoner MC, Meriam BT, Sroufe R, Houser S, Lamuraglia GM, Watkins MT, Archives of Surgery, Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion, Volume: 140(4), Pages: 344-51 April, 2005

22. Entabi F, Hashmi F, Watkins MT, Current Surgery, Angiogenesis: promise or substance? , Volume: 61(2), Pages: 146-51 March, 2004

23. Entabi F, University of Damascus- Medical School Publications (In Arabic), Diabetes and Pregnancy. Sept, 2000

Meetings/Published Abstracts:

1) Madigan MC, Entabi F, Hong G, Zuckerbraun B, Tzeng E “Nitrite Increases Fibroblast Migration and proliferation and May Represent a Viable Source of Nitric Oxide for Wound Healing. Journal of Vascular Surgery- J VASC SURG, vol. 53, no.6, pp. 88S-88S, 2011

2) Entabi F, Madigan MC, Billiar T, Tzeng E “CO Promotes Limb Recovery In Mouse Hindlimb Ischemia Independent Of HO” to be presented at Academic Surgical Congress in Las Vegas, NV in February 2012

3) Entabi F, Namkoong S, Madigan M, Tzeng E “Delayed, intermittent inhaled CO improves perfusion and limb recovery in a mouse hindlimb ischemia model” to be presented in the American College of Surgeons Annual clinical congress in San Francisco, CA in October 2011

4) Entabi F, Namkoong S, Madigan M, Tzeng E “Delayed, intermittent inhaled CO improves perfusion and limb recovery in a mouse hindlimb ischemia model” presented in the Ninth Annual Department of Surgery Research in Pittsburgh, PA in May 2011

5) Madigan M, Entabi F, Hong G, Zuckerbraun B, Tzeng E “Nitrite Increases Fibroblast Migration and Proliferation and May Represent a Viable Source of Nitric Oxide for Wound Healing” presented at the Vascular Annual Meeting in Chicago, IL in june 2011

6) Entabi F, Namkoong S, Madigan M, Tzeng E “Inhaled carbon monoxide protects skeletal muscle from ischemic injury in a murine model of hindlimb ischemia without improving angiogenesis” presented at the Academic Surgical Congress in Huntington Beach, CA in Febuary 2011

7) Entabi F, Edmonds R, McCloskey C “The Role of TLR4 and Free Fatty Acids in Hepatocellular Injury an Obese Model of Hemorrhagic Shock” presented at the Surgical Forum in Washington DC in October2010

8) Entabi F, Zuckerbraun BS, Tzeng E “Inhaled CO results in a prolonged anti-inflammatory phenotype and reduces mortality in delayed endotoxemia” presented at the Surgical Forum in Washington DC in October2010

9) Entabi F, Zuckerbraun BS, Tzeng E “Inhaled CO produces an anti-inflammatory phenotype and reduces mortality in delayed endotoxemia” presented in the Eighth Annual Department of Surgery Research in Pittsburgh, PA in May 2011

10) Entabi F, Eid G Treatment Algorithm for Morbidly Obese Patients Presenting with Ventral Hernias. American Society of Metabolic and Bariatric Surgery 27th Annual Meeting, Las Vegas, Nevada June.2010

11) Entabi F, Matthew Alef, Guiying Hong, Patricia Loughran, Donna Stolz, Edith Tzeng. Inhaled CO decreases fibrin deposition and activates fibrinolysis: A potential mechanism of vasoprotection.5th Academic Surgical Congress San Antoino, TX Feb.2010

12) Entabi F, Eid G, The Simultaneous Surgical Treatment for Ventral Hernia and Morbid Obesity. Pennsylvania Medical Society Poster Contest, Hershey, PA 10/2009

13) Entabi F, Albadawi H, Crawford RS, Jones J, Atkins MD, Watkins MT, Society of University Surgeons, San Diego, CA, Recovery impairment in diabetic rodents after limb ischemia-reperfusion 02/2006

14) Entabi F, Albadawi H, Crawford RS, Jones J, Atkins MD, Conrad MF, Watkins MT, Association of Academic Surgeons, San Diego, CA, PARP inhibition confers protection against limb ischemia-reperfusion injury in diabetic rodents, 02/2006

15) Crawford RS, Hashmi FF, Jones J, Albadawi H, Entabi F, Atkins MD, Conrad MF, Watkins MT, Society of University Surgeons, San Diego, CA, A novel model of acute murine hindlimb ischemia 02/2006

16) Conrad MF, Stone DH, Albadawi H, Entabi F, Watkins MT, Association of Academic Surgeons, San Diego, CA, Local Administration of the Poly ADP-Ribose Polymerase (PARP) Inhibitor PJ34 During Hindlimb Ischemia Modulates Skeletal Muscle Reperfusion Injury 02/2006

17) Jones JE, Al-Badawi H, Atkins MD, Entabi F, Stone DH, Watkins MT, Association of Academic Surgeons, San Diego, CA, The absence of TOLL-like receptor-4 does not improve survival or protect against spinal cord injury after thoracic aortic ischemia reperfusion mice, 02/2006

18) Albadawi H, Entabi F, Conrad MF, Stone DH, Watkins MT, American College of Surgeons Clinical Congress, San Francisco, CA, Novel Role of Toll-like Receptor 4 in limb Ischemia-Reperfusion, 10/2005

19) Stone DH, AlBadawi H, Conrad MF, Entabi F, Stoner MC, Cambria RP, Watkins MT. American College of Surgeons, San Francisco, CA, COX-2 Inhibition Enhances Spinal Cord Mitochondrial Activity in a Murine Model of Thoracic Aortic Ischemia Reperfusion Injury, 10/ 2005.

20) Stone DH, Conrad MF AlBadawi H, Entabi F, Stoner MC, Cambria RP, Watkins MT, New England Society of Vascular Surgery, Stowe, VT. PJ34 Enhanced Spinal Cord Tissue Viability and Differential Gene Expression in a Murine Model of Thoracic Aortic Reperfusion Injury, 09 / 2005

21) Conrad MF, Stone DH, Albadawi H, Entabi F, Watkins MT, New England Surgical Society, Local Administration of the Poly ADP-Ribose Polymerase (PARP) Inhibitor PJ34 During Hindlimb Ischemia Modulates Skeletal Muscle Reperfusion Injury, 09 / 2005

22) Entabi F, Albadawi H, Stone DH, Sroufe RL, Conrad MF, Watkins MT, New England Surgical Society, Bretton Woods, NH, Differential Response Between Type 1 and Type 2 Diabetes to Ischemia Reperfusion Injury, 09 / 2005

23) Entabi F, Albadawi H, Stone DH, Conrad MF, Watkins MT, American Diabetes Association San Diego, CA, Impaired Recovery in Db Mice after Limb Ischemia Reperfusion, 06 / 2005

24) Stone DH, AlBadawi H, Conrad MF, Entabi F, Stoner MC, Cambria RP, Watkins MT, Society of Vascular Surgery, Chicago, IL , PJ34, A Poly-ADP-Ribose Polymerase Inhibitor, Modulates Visceral Mitochondrial Activity and CD14 Expression Following Thoracic Aortic Ischemia Reperfusion , 06 / 2005

25) Stone DH, AlBadawi H, Conrad MF, Entabi F, Stoner MC, Cambria RP, Watkins MT, Arteriosclerosis, Thrombosis, and Vascular Biology, Washington DC. PJ34 Enhanced Spinal Cord Tissue Viability and Differential Gene Expression in a Murine Model of Thoracic Aortic Reperfusion Injury, 04 / 2005

26) Albadawi H, Conrad MF, Entabi F, Stone DH, LaMuraglia GM, Watkins MT. , Society for Vascular Surgery Washington, DC, Border Zone Region is a Source of Cytokines and Pro-thrombotic Activity During Limb Ischemia. , 04 / 2005

27) Stone DH, Conrad MF, Stoner MC, Al-Badawi H, Entabi F, Cambria RP, Watkins MT. , Vascular Surgery Fellows Meeting, New York, NY (Awarded The Thomas F. O'Donnell Award for Best Paper Presentation) , PJ34, a Poly-ADP Ribose Polymerase Inhibitor, Modulates Renal Viability Following Thoracic Aortic Ischemia Reperfusion. , 04 / 2005

28) Entabi F, Albadawi H, Stone DH, Sroufe RL, Conrad MF, Watkins MT, Society of University Surgeons, Nashville, TN, Leptin Pathway: A Potential Target For Skeletal Muscle Ischemia Reperfusion Injury Treatment, 02 / 2005

29) Stone DH, AlBadawi H, Conrad MF, Entabi F, Stoner MC, Cambria RP, Watkins MT, Society of University Surgeons, Nashville, TN, PJ34, a Poly-ADP Ribose Polymerase Inhibitor, Modulates Renal Viability Following Thoracic Aortic Ischemia Reperfusion, 02 / 2005